SCHEMBL21550282

SCHEMBL21550282

CC(Cl)Nc1ccnc(Cl)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.35
▸ GRM5 P41594 2/20 0.34
▸ HTR7 P34969 2/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ JAK3 P52333 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ SYK P43405 1/20 0.32
▸ ACHE P22303 2/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ NR4A2 P43354 1/20 0.32
▸ TGFBR1 P36897 1/20 0.32
▸ CCR4 P51679 1/20 0.32
▸ PLK1 P53350 1/20 0.32
▸ MAPK14 Q16539 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ CCNA2 P20248 1/20 0.31
▸ CDK2 P24941 1/20 0.31
▸ CCNA1 P78396 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1774897 0.86 GAA (0.42) ESR1GRM5GAATDP1NR4A2
SCHEMBL20685774 0.85 MAPK14 (0.42) ESR1GRM5NR4A2PLK1MAPK14
SCHEMBL5756104 0.83 GRM5 (0.36) ESR1GRM5HTR7JAK2JAK3
SCHEMBL20612065 0.80 HCAR3 (0.43) ESR1TDP1ALDH1A1SMN1; SMN2CCR4
SCHEMBL11306797 0.80 CCR4 (0.34) ESR1GRM5HTR7JAK2JAK3
SCHEMBL28277650 0.80 HCAR3 (0.43) ESR1TDP1ALDH1A1SMN1; SMN2CCR4
SCHEMBL20956373 0.79 CCR4 (0.36) ESR1GRM5HTR7CCR4
SCHEMBL28937980 0.78 CRHR1 (0.42) ESR1CCR4CCNA2CDK2
SCHEMBL29607425 0.78 CRHR1 (0.42) ESR1CCR4CCNA2CDK2
SCHEMBL20911283 0.78 NR4A2 (0.34) ESR1GRM5JAK2JAK3NR4A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194383-B1 QUINOLINONE PYRIMIDINES COMPOSITIONS AS MUTANT-ISOCITRATE DEHYDROGENASE INHIBITORS FORMA THERAPEUTICS INC (US) 2019-11-06 — — EP disclosed
Send feedback